Results · Apr-Jun 2026
Sampre Nutritions Q1 FY27 results
Sales grew 37% to ₹14.8 crore from ₹10.9 crore in Apr-Jun 2025.
Operating profit grew 8% to ₹1.5 crore, an operating margin of 10.1% (down 2.6 points from a year ago).
Net profit fell 1% to ₹0.7 crore from ₹0.71 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −2%, net profit −35%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 14.8 | 10.9 | +37% |
| Operating profit (EBITDA) | 1.5 | 1.4 | +8% |
| Operating margin | 10.1% | 12.7% | −2.6 pts |
| Net profit | 0.7 | 0.7 | −1% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.